A Curated Platform of Equity & Options Market Intelligence
Select Page

AKUS

Search by
TICKER SYMBOL

Akouos Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

13.29

0.14

(1.065%)

Volume:

0

52 week range:

0 - 13.33

Market Cap:

490.879M

Company Description:

Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals living with disabling hearing loss worldwide. Leveraging its precision genetic medicine platform that incorporates a proprietary adeno-associated viral (AAV) vector library and a novel delivery approach, Akouos is focused on developing precision therapies for forms of sensorineural hearing loss. Headquartered in Boston, Akouos was founded in 2016 by leaders in the fields of neurotology, genetics, inner ear drug delivery, and AAV gene therapy.